Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
No Result
View All Result

France’s Sanofi to buy Medivation

byCT Report
22/08/2016
in Uncategorized
Share on FacebookShare on Twitter

PARIS: The Financial Times and Bloomberg were among news groups reporting that an announcement of a takeover could come early this week.

San Francisco-based Medivation produces the prostate-cancer treatment Xtandi. France’s Sanofi had tried to buy Medivation, and Merck & Co and Celgene were also said to have considered bids.

You might also like

Commerce ministry seeks one-year ban on transfer of used cars imported by overseas Pakistanis

14/11/2026

Pakistan extends 40.47pc anti-dumping duty to Galvalume steel imports from China

14/11/2026

Reuters reported on Sunday that Pfizer had agreed in principle to pay about $80 per share for Medivation, a substantial premium to the $52.50 offer for Medivation that France’s Sanofi made in April. Pfizer’s drugs portfolio includes the breast cancer treatment Ibrance and several other promising immuno-oncology products.

In addition to Xtandi, which is already approved for sale in the US and is forecast to generate $5.7bn in sales by 2020, Medivation has a breast cancer treatment under development, Talazoparib.

Medivation was founded in 2004. Its share price has more than doubled in the past six months on takeover talk. In April, Pfizer scrapped a planned merger with Ireland’s Allergan after the deal hit trouble because of plans to change US tax laws. The US Treasury had announced plans to prevent deals known as “inversions”, where a US firm merges with a company in a country with a lower tax rate.

The Pfizer-Allergan deal, valued at $160bn, would have been the biggest example of an “inversion”. It would also have been the biggest pharmaceutical deal in history.

Related Stories

Commerce ministry seeks one-year ban on transfer of used cars imported by overseas Pakistanis

byCT Report
14/11/2026

ISLAMABAD: The Ministry of Commerce has asked provincial governments to strictly enforce the one-year restriction on transferring used vehicles imported...

Pakistan extends 40.47pc anti-dumping duty to Galvalume steel imports from China

byCT Report
14/11/2026

KARACHI: The National Tariff Commission (NTC) has extended the existing 40.47% anti-dumping duty on Chinese galvanised steel to imports of...

FBR assessment exposes major gaps in tax officers’ competence

byCT Report
14/11/2026

KARACHI: An assessment conducted by the Federal Board of Revenue (FBR) has identified significant weaknesses in the ability of inland...

PLL invites bids for two LNG cargoes

byCT Report
14/11/2026

KARACHI: State-owned Pakistan LNG Limited (PLL) has invited bids from reputed international suppliers for the delivery of two liquefied natural...

Next Post

Irish company Kingspan H1 profit,revenue increase

  • Terms and Conditions
  • Disclaimer

© 2011 Customs Today -World's first newspaper on customs. Customs Today.

No Result
View All Result
  • Transfers and Postings
  • Latest News
  • Karachi
  • Islamabad
  • Lahore
  • National
  • Chambers & Associations
  • Business
  • About Us

© 2011 Customs Today -World's first newspaper on customs. Customs Today.